Business · 11/07/2018Updated: 10/17/2026 · 1 min read
FDA Requests Public Comment on Proposed Collection of Information for Prescription Drug User Fee Act Products
Summary
The Food and Drug Administration is seeking public input on a proposed collection of information related to formal meetings with sponsors and applicants for Prescription Drug User Fee Act products, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →